These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3400681)

  • 1. Effect of dose and schedule on cefoperazone pharmacodynamics in an in vitro model of infection in a neutropenic host.
    Zinner SH; Dudley MN; Gilbert D; Bassignani M
    Am J Med; 1988 Jul; 85(1A):56-8. PubMed ID: 3400681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activity of cefoperazone and cefoperazone plus sulbactam in a neutropenic site model.
    Fasching CE; Moody JA; Sinn LM; Tenquist J; Gerding DN; Peterson LR
    Diagn Microbiol Infect Dis; 1991; 14(2):147-55. PubMed ID: 1873973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
    Rotstein C; Cimino M; Winkey K; Cesari C; Fenner J
    Am J Med; 1988 Jul; 85(1A):36-43. PubMed ID: 3041817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
    Iwata S; Sato Y; Iwasaki Y; Hayano S; Wakabayashi R; Kojima Y; Akita H; Sunakawa K; Oikawa T; Osano M
    Jpn J Antibiot; 1984 Oct; 37(10):1831-45. PubMed ID: 6094863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical laboratory approach for estimating effective administrative dose of cefoperazone. Evaluation of disc susceptibility test and its interpretation system].
    Matsuo K; Uete T
    Jpn J Antibiot; 1988 Oct; 41(10):1418-29. PubMed ID: 3204655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of cefoperazone in the field of obstetrics and gynecology. Susceptibility of clinical isolates to cefoperazone and cefoperazone concentrations in the exudate of the pelvic dead space].
    Cho N; Kimura T; Suzuki H; Fukunaga K; Kunii K; Komoriyama Y
    Jpn J Antibiot; 1984 Sep; 37(9):1607-19. PubMed ID: 6512980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical laboratory approach for estimating effective administrative dose of sulbactam/cefoperazone].
    Uete T; Matsuo K
    Jpn J Antibiot; 1988 Nov; 41(11):1578-90. PubMed ID: 3210296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of sulbactam on the activity of cefoperazone against various clinical isolates].
    Uete T; Matsuo K
    Jpn J Antibiot; 1989 Apr; 42(4):896-909. PubMed ID: 2769941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Laboratory and clinical studies of sulbactam/cefoperazone in the pediatric field].
    Nishimura T; Tabuki K; Takashima T; Takagi M
    Jpn J Antibiot; 1984 Oct; 37(10):1880-92. PubMed ID: 6094866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on sulbactam/cefoperazone in the field of pediatrics].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
    Jpn J Antibiot; 1984 Oct; 37(10):1859-79. PubMed ID: 6094865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bacteriological, pharmacokinetic and clinical studies on sulbactam/cefoperazone in the pediatric field].
    Fujii R; Meguro H; Arimasu O; Mashiko J; Tajima T; Nonaka C; Nagamatsu I; Sato Y; Honjo T; Watanabe A
    Jpn J Antibiot; 1984 Dec; 37(12):2427-56. PubMed ID: 6098739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of liposomal cefoperazone against Pseudomonas aeruginosa in a granulocytopenic mouse model of acute lung infection.
    Di Rocco PH; Nacucchio MC; Sordelli DO; Mancuso F; Hooke AM
    Infection; 1992; 20(6):360-4. PubMed ID: 1293058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The post-antibiotic effect of antimicrobial combinations in a neutropenic murine thigh infection model.
    Gudmundsson S; Einarsson S; Erlendsdottir H; Moffat J; Bayer W; Craig WA
    J Antimicrob Chemother; 1993 May; 31 Suppl D():177-91. PubMed ID: 8335520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two schedules of cefoperazone plus aztreonam in the treatment of neutropenic patients with fever.
    Bodey G; Reuben A; Elting L; Kantarjian H; Keating M; Hagemeister F; Koller C; Velasquez W; Papadopoulos N
    Eur J Clin Microbiol Infect Dis; 1991 Jul; 10(7):551-8. PubMed ID: 1915397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Laboratory and clinical study of sulbactam/cefoperazone (SBT/CPZ) on bacterial prostatitis].
    Suzuki K; Horiba M
    Hinyokika Kiyo; 1991 Oct; 37(10):1333-43. PubMed ID: 1755429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro comparative activity of 4 beta-lactams against Pseudomonas aeruginosa. Role of cefoperazone].
    Joly-Guillou ML; Bergogne-Berezin E; Verin-Prevost C
    Pathol Biol (Paris); 1984 May; 32(5):408-11. PubMed ID: 6429612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefoperazone plus mezlocillin for empiric therapy of febrile cancer patients.
    Jones P; Bodey GP; Rolston K; Fainstein V; Riccardi S
    Am J Med; 1988 Jul; 85(1A):3-8. PubMed ID: 3400680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical studies of cefoperazone in neurosurgery].
    Kitamura K; Shimizu T; Abe H; Suzuki J; Tanaka R; Nagai H; Yamamoto S; Handa H; Nishimoto A; Matsuoka K
    Jpn J Antibiot; 1986 Jan; 39(1):63-74. PubMed ID: 2939268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The serum bactericidal activity of latamoxef (moxalactam), cefoperazone and cefotaxime.
    McNamee W; Drusano GL; Tatem BA; Standiford HC
    J Antimicrob Chemother; 1984 Nov; 14(5):491-7. PubMed ID: 6096348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative susceptibility patterns of common clinical isolates to cefoperazone: 1981 to 1987.
    Jenkins SG
    Am J Med; 1988 Jul; 85(1A):52-5. PubMed ID: 3135749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.